Centene Corporation CNC

La empresa Centene Corporation es una compañía de atención médica multinacional. La empresa brinda servicios a programas de atención médica patrocinados por el gobierno y comerciales, centrándose en individuos con seguro insuficiente o sin seguro. También ofrece programas de educación y divulgación para informar y ayudar a los miembros a acceder a servicios de atención médica adecuados. Opera a través de dos segmentos: Cuidado Administrado y Servicios Especiales. El segmento de Cuidado Administrado brinda cobertura de planes de salud a individuos a través de programas subsidiados por el gobierno y comerciales. Su segmento de Servicios Especiales incluye empresas que ofrecen servicios y productos de atención médica diversificados a su segmento de Cuidado Administrado y a otros clientes externos. Ofrece una variedad de productos y servicios de atención médica, principalmente a través de Medicaid, Medicare y productos comerciales.

CNC hizo una división de acciones (split) de 2:1 el 7 de febrero de 2019: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 1 oct

  Best Growth Stocks to Buy for October 1st

  Recent economic data shows PCE inflation came in softer than expected while Q2 GDP exceeded expectations. Market attention is now focused on the upcoming Friday employment report. Three stocks with Zacks Rank #1 ratings are highlighted: Centene (healthcare), ATI Inc. (specialty materials), and BP (energy), all showing positive earnings estimate revisions.

  

• Zacks Investment Research 1 oct

  Zacks.com featured highlights include Banco Macro, Centene, Enersys, Gibraltar Industries and Kennametal

  Zacks.com highlights five stocks with low price-to-book ratios and strong growth potential: Banco Macro, Centene, EnerSys, Gibraltar Industries, and Kennametal. These companies are identified as potentially undervalued with attractive return prospects based on valuation metrics and projected earnings growth rates ranging from 15% to 32.4% over 3-5 years.

  

• Zacks Investment Research 30 sept

  5 Low P/B Stocks With Attractive Value and Strong Growth Potential

  Five stocks with low price-to-book ratios have been identified as potentially undervalued investment opportunities. These companies—Banco Macro, Centene, EnerSys, Gibraltar Industries, and Kennametal—all meet key value-screening criteria with Zacks Rank #1 or #2 ratings and Value Scores of A or B. The stocks show projected 3-5-year EPS growth ranging from 15% to 32.4%, with Centene leading at 32.4% growth.

  

• Zacks Investment Research 29 sept

  Best Growth Stocks to Buy for September 29th

  Zacks highlights three stocks with Rank #1 (Strong Buy) ratings as of September 29th: Centene (CNC), a diversified healthcare company with 7% earnings estimate growth; monday.com (MNDY), a software platform provider with 22.5% earnings estimate growth; and ATI Inc. (ATI), a specialty materials producer with 12.1% earnings estimate growth. All three companies show favorable PEG ratios compared to their respective industries.

  

• Zacks Investment Research 23 sept

  Zacks.com featured highlights include Centene, BrightSpring Health Services and Delek US

  Following a sharp market rally driven by declining oil prices and AI-related stocks, Zacks highlights three momentum stocks with strong year-to-year gains but recent weekly pullbacks: Centene Corp., BrightSpring Health Services, and Delek US Holdings. All three stocks have Momentum Score A ratings and are positioned as potential beneficiaries of momentum investing strategies despite geopolitical tensions in the Middle East.